Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
MicroRNA-199a-5p (miR-199a-5p) and -3p are enriched in the myocardium, but it is unknown whether miR-199a-5p and -3p are co-expressed in cardiac remodeling and what roles they have in cardiac hypertrophy and fibrosis. We show that miR-199a-5p and -3p are co-upregulated in the mouse and human myocard...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e264f9859a5f4bd783e488783367e2ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e264f9859a5f4bd783e488783367e2ec |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e264f9859a5f4bd783e488783367e2ec2021-11-04T04:28:37ZDiverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis2162-253110.1016/j.omtn.2021.10.013https://doaj.org/article/e264f9859a5f4bd783e488783367e2ec2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2162253121002560https://doaj.org/toc/2162-2531MicroRNA-199a-5p (miR-199a-5p) and -3p are enriched in the myocardium, but it is unknown whether miR-199a-5p and -3p are co-expressed in cardiac remodeling and what roles they have in cardiac hypertrophy and fibrosis. We show that miR-199a-5p and -3p are co-upregulated in the mouse and human myocardium with cardiac remodeling and in Ang-II-treated neonatal mouse ventricular cardiomyocytes (NMVCs) and cardiac fibroblasts (CFs). miR-199a-5p and -3p could aggravate cardiac hypertrophy and fibrosis in vivo and in vitro. PPAR gamma coactivator 1 alpha (Ppargc1a) and sirtuin 1 (Sirt1) were identified as target genes to mediate miR-199a-5p in promoting both cardiac hypertrophy and fibrosis. However, miR-199a-3p aggravated cardiac hypertrophy and fibrosis through targeting RB transcriptional corepressor 1 (Rb1) and Smad1, respectively. Serum response factor and nuclear factor κB p65 participated in the upregulation of miR-199a-5p and -3p in Ang-II-treated NMVCs and mouse CFs, and could be conversely elevated by miR-199a-5p and -3p. Together, Ppargc1a and Sirt1, Rb1 and Smad1 mediated the pathological effect of miR-199a-5p and -3p by promoting cardiac hypertrophy and fibrosis, respectively. This study suggests a possible new strategy for cardiac remodeling therapy by inhibiting miR-199a-5p and -3p.Ni ZengYu-Qing HuangYu-Min YanZhi-Qin HuZhuo ZhangJia-Xin FengJi-Shen GuoJie-Ning ZhuYong-Heng FuXi-Pei WangMeng-Zhen ZhangJin-Zhu DuanXi-Long ZhengJin-Dong XuZhi-Xin ShanElsevierarticlemicroRNAcardiac hypertrophycardiac fibrosismicroRNA-199a-5pmicroRNA-199a-3pTherapeutics. PharmacologyRM1-950ENMolecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 1035-1050 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
microRNA cardiac hypertrophy cardiac fibrosis microRNA-199a-5p microRNA-199a-3p Therapeutics. Pharmacology RM1-950 |
spellingShingle |
microRNA cardiac hypertrophy cardiac fibrosis microRNA-199a-5p microRNA-199a-3p Therapeutics. Pharmacology RM1-950 Ni Zeng Yu-Qing Huang Yu-Min Yan Zhi-Qin Hu Zhuo Zhang Jia-Xin Feng Ji-Shen Guo Jie-Ning Zhu Yong-Heng Fu Xi-Pei Wang Meng-Zhen Zhang Jin-Zhu Duan Xi-Long Zheng Jin-Dong Xu Zhi-Xin Shan Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis |
description |
MicroRNA-199a-5p (miR-199a-5p) and -3p are enriched in the myocardium, but it is unknown whether miR-199a-5p and -3p are co-expressed in cardiac remodeling and what roles they have in cardiac hypertrophy and fibrosis. We show that miR-199a-5p and -3p are co-upregulated in the mouse and human myocardium with cardiac remodeling and in Ang-II-treated neonatal mouse ventricular cardiomyocytes (NMVCs) and cardiac fibroblasts (CFs). miR-199a-5p and -3p could aggravate cardiac hypertrophy and fibrosis in vivo and in vitro. PPAR gamma coactivator 1 alpha (Ppargc1a) and sirtuin 1 (Sirt1) were identified as target genes to mediate miR-199a-5p in promoting both cardiac hypertrophy and fibrosis. However, miR-199a-3p aggravated cardiac hypertrophy and fibrosis through targeting RB transcriptional corepressor 1 (Rb1) and Smad1, respectively. Serum response factor and nuclear factor κB p65 participated in the upregulation of miR-199a-5p and -3p in Ang-II-treated NMVCs and mouse CFs, and could be conversely elevated by miR-199a-5p and -3p. Together, Ppargc1a and Sirt1, Rb1 and Smad1 mediated the pathological effect of miR-199a-5p and -3p by promoting cardiac hypertrophy and fibrosis, respectively. This study suggests a possible new strategy for cardiac remodeling therapy by inhibiting miR-199a-5p and -3p. |
format |
article |
author |
Ni Zeng Yu-Qing Huang Yu-Min Yan Zhi-Qin Hu Zhuo Zhang Jia-Xin Feng Ji-Shen Guo Jie-Ning Zhu Yong-Heng Fu Xi-Pei Wang Meng-Zhen Zhang Jin-Zhu Duan Xi-Long Zheng Jin-Dong Xu Zhi-Xin Shan |
author_facet |
Ni Zeng Yu-Qing Huang Yu-Min Yan Zhi-Qin Hu Zhuo Zhang Jia-Xin Feng Ji-Shen Guo Jie-Ning Zhu Yong-Heng Fu Xi-Pei Wang Meng-Zhen Zhang Jin-Zhu Duan Xi-Long Zheng Jin-Dong Xu Zhi-Xin Shan |
author_sort |
Ni Zeng |
title |
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis |
title_short |
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis |
title_full |
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis |
title_fullStr |
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis |
title_full_unstemmed |
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis |
title_sort |
diverging targets mediate the pathological roleof mir-199a-5p and mir-199a-3p by promoting cardiac hypertrophy and fibrosis |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/e264f9859a5f4bd783e488783367e2ec |
work_keys_str_mv |
AT nizeng divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT yuqinghuang divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT yuminyan divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT zhiqinhu divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT zhuozhang divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT jiaxinfeng divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT jishenguo divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT jieningzhu divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT yonghengfu divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT xipeiwang divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT mengzhenzhang divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT jinzhuduan divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT xilongzheng divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT jindongxu divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis AT zhixinshan divergingtargetsmediatethepathologicalroleofmir199a5pandmir199a3pbypromotingcardiachypertrophyandfibrosis |
_version_ |
1718445304374624256 |